SCHEMBL22003261

SCHEMBL22003261

O=C(O)CNC(=O)C1=C(O)N(c2ccc(-c3ccco3)cc2)C(=O)N(CCC2CC2)C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.34
TAAR1 Q96RJ0 2/20 0.32
CYP2C9 P11712 1/20 0.32
P2RX3 P56373 1/20 0.32
FFAR1 O14842 1/20 0.32
EGLN1 Q9GZT9 4/20 0.31
BBOX1 O75936 1/20 0.31
ASPH Q12797 1/20 0.31
KDM8 Q8N371 1/20 0.31
RECQL P46063 2/20 0.31
HSD17B10 Q99714 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
CCR3 P51677 1/20 0.31
CYP2D6 P10635 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ALOX15 P16050 1/20 0.31
MAPK1 P28482 1/20 0.31
CYP2C19 P33261 1/20 0.31
BLM P54132 1/20 0.31
GPR119 Q8TDV5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22003121 0.81 EGLN1 (0.43) HIF1AEGLN1TDP1ALDH1A1
SCHEMBL3415752 0.74 HIF1A (0.45) HIF1AEGLN1BBOX1ASPHKDM8
SCHEMBL3419484 0.67 HSD17B10 (0.38) TAAR1CYP2C9P2RX3RECQLHSD17B10
SCHEMBL14342749 0.65 TAAR1 (0.44) TAAR1CYP2C9FFAR1HSD17B10ALDH1A1
SCHEMBL24005735 0.61 EGLN1 (0.46) CYP2C9EGLN1CYP2D6CYP2C19KMT2A
SCHEMBL21129210 0.60 ENPP2 (0.57) EGLN1BBOX1ASPHKDM8ALDH1A1
SCHEMBL19267141 0.60 TAAR1 (0.32) TAAR1CYP2C9FFAR1ALDH1A1GPR119
SCHEMBL21129642 0.58 HIF1A (0.38) HIF1AEGLN1BBOX1ASPHKDM8
SCHEMBL24005450 0.58 LIPG (0.39) EGLN1
SCHEMBL25954462 0.58 EGLN1 (0.46) EGLN1BBOX1ASPHKDM8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200157055-A1 Prolyl Hydroxylase Inhibitors GLAXOSMITHKLINE LLC (US) 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200157055-A1 Prolyl Hydroxylase Inhibitors HIF1AN, EGLN3, EGLN2 HIF1A 4/4885TAAR1 3871/4885CYP2C9 1080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.